Review Articles

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies

Department of Dermatology
Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, Madrid;Hospital Universitario Fundación Jiménez Díaz, Madrid, CIBERONC, Madrid
Pathology, Hospital Universitario Marques de Valdecilla, Santander
Dermatology Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
Department of Dermatology
Department of Pathology, Hospital Universitario Fundación Jiménez Díaz, Madrid;Hospital Universitario Fundación Jiménez Díaz, Madrid, CIBERONC, Madrid
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.197152